Indications and Purposes
| 1 Indications And Usage Cosopt ® Is Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension Who Are Insufficiently Responsive To Beta-Blockers (Failed To Achieve Target Iop Determined After Multiple Measurements Over Time). The Iop-Lowering Of Cosopt Administered Twice A Day Was Slightly Less Than That Seen With The Concomitant Administration Of 0.5% Timolol Administered Twice A Day And 2% Dorzolamide Administered Three Times A Day [See Clinical Studies ( 14 )]. Cosopt Is A Carbonic Anhydrase Inhibitor With A Beta-Adrenergic Receptor Blocking Agent Indicated For The Reduction Of Elevated Intraocular Pressure (Iop) In Patients With Open-Angle Glaucoma Or Ocular Hypertension Who Are Insufficiently Responsive To Beta-Blockers. The Iop-Lowering Of Cosopt Twice Daily Was Slightly Less Than That Seen With The Concomitant Administration Of 0.5% Timolol Twice Daily, And 2% Dorzolamide Three Times Daily. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Dorzolamide Hydrochloride |
|
ZINC1530621 |
| 2. Timolol Maleate |
|
ZINC2176 |